Aβ42 gene vaccine prevents Aβ42 deposition in brain of double transgenic mice

This publication has 35 references indexed in Scilit:

• Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid
  Journal of Clinical Investigation, 2006
• Nonviral Aβ DNA vaccine therapy against Alzheimer’s disease: Long-term effects and safety
  Proceedings of the National Academy of Sciences, 2006
• Role of the APP Promoter in Alzheimer's Disease: Cell Type‐Specific Expression of the β‐Amyloid Precursor Protein
  Annals of the New York Academy of Sciences, 2004
• Endogenous IL-4 and IFN-γ are essential for expression of Th2, but not Th1 cytokine message during the early differentiation of human CD4+ T helper cells
  Human Immunology, 2004
• Standardization of measurement of β-amyloid_(1-42)in cerebrospinal fluid and plasma
  Amyloid, 2000
• APP Gene Promoter Constructs Are Preferentially Expressed in the CNS and Testis of Transgenic Mice
  Biochemical and Biophysical Research Communications, 1997
• Mechanisms of Neuronal Degeneration in Alzheimer's Disease
  Neuron, 1996
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
  Neuron, 1994
• GFAP and Astrogliosis
  Brain Pathology, 1994
• Amyloid β-peptide is produced by cultured cells during normal metabolism
  Nature, 1992